Adit L. Tal

https://assets.montefioreeinstein.org/profiles/images/physphoto/Tal_Adit_MD_420x504.jpg

First Name

Adit

Last Name

Tal

NPI

1922445972

Faculty ID

16130

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

56692

Biography

<p>Adit Tal, MD, is an Attending Physician at Children&rsquo;s Hospital at Montefiore Einstein (CHAM) and an Assistant Professor of Pediatric Hematology, Oncology, Marrow and Blood Cell Transplantation at our Albert Einstein College of Medicine. Since joining the Montefiore team, Dr. Tal&rsquo;s clinical focus has been the treatment of pediatric leukemia and lymphoma, and the supportive care of children with cancer.</p><p>Dr. Tal received her Bachelor of Arts in Neuroscience from Johns Hopkins University in 2008, followed by her Doctorate of Medicine at the Sackler School of Medicine. She began her postgraduate training in 2013 at CHAM and Albert Einstein College of Medicine, following her Pediatrics residency with a Pediatric Hematology/Oncology fellowship.</p><p>Building on her clinical practices, Dr. Tal&rsquo;s research focuses on novel therapeutic targets for advanced treatments in metastatic osteosarcoma. She is examining a signaling pathway crucial to bone development and differentiation, and targeting this pathway to treat osteosarcoma. Her work has been published in numerous peer-reviewed articles.</p><p>Dr. Tal is board certified by the American Board of Pediatrics and is a member of many professional societies including the American Academy of Pediatrics, the Children&rsquo;s Oncology Group, and the American Society of Clinical Oncology. She is also a member of the Professional Development Committee with the American Society of Pediatric Hematology/Oncology, and is a volunteer pediatric oncologist at Happiness Is Camping, a residential camp for children with cancer and their families.</p>

Is Open Scheduling

Off

Jonathan Shuter

https://assets.montefioreeinstein.org/profiles/images/physphoto/Shuter_Jonathan_420x504.jpg

First Name

Jonathan

Last Name

Shuter

NPI

1578648341

Faculty ID

3619

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3917

Is Open Scheduling

Off

Mark Shlomovich

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f00957b0-d372-11ed-b9ca-f36b2b5dc5fe.jpg

First Name

Mark

Last Name

Shlomovich

NPI

1790065910

Faculty ID

15549

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

29419

Biography

<p>Mark Shlomovich, MD, is Director, Extracorporeal Liver Support and Director, Pediatric Critical Care Transport at Children&rsquo;s Hospital at Montefiore and Assistant Professor, Pediatrics at Montefiore-Einstein. Dr. Shlomovich&rsquo;s clinical focus is on the care of critically ill children with abdominal organ failure, transplantation and post-surgical care. He also focuses on the safe transportation of critically ill children.</p><p>In 2006, Dr. Shlomovich earned his Bachelor of Science in biology from Towson University. He then attended University of Connecticut School of Medicine earning his Doctor of Medicine in 2010. His postgraduate training began at SUNY Downstate Medical Center with a four-year pediatric residency, where he was Chief Pediatric Resident in his final year. He then came to Children's Hospital at Montefiore for a pediatric critical care fellowship, which he completed in 2017.</p><p>Dr. Shlomovich&rsquo;s research interests are in the use of artificial liver support technology, as well as the care of children in liver failure before and after transplantation. In addition, he investigates the safety and efficiency of the transportation of critically ill children. He has shared his research through peer-reviewed journals and abstracts, and is an ad hoc reviewer for BMC Nephrology.</p><p>Dr. Shlomovich is board certified in general pediatrics and pediatric critical care medicine. He is a member of the Society of Critical Care Medicine and the American Academy of Pediatrics.</p>

Is Open Scheduling

Off

Theresa M. Serra

https://assets.montefioreeinstein.org/profiles/images/Serra_Theresa_MD_2x.jpg

First Name

Theresa

Last Name

Serra

NPI

1609164078

Faculty ID

14280

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric Medicine

Elsevier Profile

EMR ID

55674

Biography

<p class="MsoNormal">Theresa Serra, MD, joined the CHAM hospitalist division in 2014 after working as a pediatric hospitalist at New York Presbyterian/Lower Manhattan Hospital. Her interests include clinical research and medical education. She has conducted an IRB approved retrospective chart review examining readmission rates in pediatric patients diagnosed with osteomyelitis. Dr. Serra is currently developing a medical Spanish curriculum for faculty members in order to improve communication between patients, families and providers. Along with Courtney McNamara, MD, Dr. Serra is a co-leader of a multidisciplinary committee dedicated to standardizing and improving quality of care for patients hospitalized with the diagnosis of failure to thrive. Dr. Serra is also working on an initiative to identify vaccine delinquency in the inpatient setting through the use of SMART reports.</p> <p class="MsoNormal">Dr. Serra is also collaborating with Lindsey Douglas, MD, MSCR, in an IRB approved quality improvement (QI) project to improve transition-of-care communication between hospitalists and primary care providers and to facilitate the establishment of medical homes. Dr. Serra is also a member of a subcommittee that leads monthly journal clubs/case conferences for pediatric hospitalists.</p>

Is Open Scheduling

Off

Alexander I. Sankin

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/6a135040-3a87-11ed-8158-59ecbd24247c.jpg

First Name

Alexander

Last Name

Sankin

NPI

1982866570

Faculty ID

14891

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Sankin is an academic surgeon in the Department of Urology, at Montefiore Medical Center with a clinical focus on surgical approaches to the management of urologic malignancies of the upper urinary tract and bladder. His academic focus is divided between clinical and translational research studying emerging treatments and techniques central to the surgical care of patients with urologic cancers.&nbsp;</p>
<p>Dr. Sankin is the site-Principal Investigator for multiple clinical trials studying novel therapeutics for patients with bladder cancer who wish to avoid radical cystectomy. As an active member of multiple clinical trial consortiums including Eastern Cooperative Oncology Group and the Society of Urologic Oncology Clinical Trials Consortium, Dr. Sankin speardeaded the development of a bladder cancer clinical trials program at Einstein.&nbsp;</p>
<p>His translational research focuses on characterizing the tumor immune microenvironment of bladder tumors and the role of novel checkpoint molecules as relevant therpeutic targets. &nbsp;</p>
<p>&nbsp;</p>

Research Areas

Expert Tags

Areas of Expertise

Expert Summary

<p>Dr. Sankin current research program focuses on the translational application of immune-oncology to the treatment of urologic cancer.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Sankin's&nbsp;clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Building on his clinical focus, Dr. Sankin&rsquo;s research centers on bladder-preserving treatment options in patients with high-risk bladder cancer and the development of new immunotherapies for bladder cancer.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p align="left">Clark TW,&nbsp;Sankin A, Becske T, Nelson PK, Fox M.&nbsp;&nbsp;Stent-assisted Gugliemi detachable coil repair of wide-necked renal artery aneurysm using 3-D angiography.&nbsp;&nbsp;Vasc Endovascular Surg 2008 Jan; 41(6):528-32</p>
<p align="left">Tareen B,&nbsp;Sankin A, Godoy G, Temkin S, Lepor H, Taneja SS.&nbsp;Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort<em>.</em>&nbsp;Urology.&nbsp;&nbsp;2009 Feb;73(2):351-4</p>
<p align="left">Tareen B, Godoy G,&nbsp;Sankin A, Temkin S, Lepor H, Taneja SS.&nbsp;&nbsp;Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.&nbsp;J Urol.&nbsp;&nbsp;2009 Mar;181(3):1082-9</p>
<p align="left">Tareen B, Godoy G,&nbsp;Sankin A, Temkin S, Lepor H, Taneja SS.&nbsp;&nbsp;Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?&nbsp;&nbsp;BJU Int. 2009 Jul;104(2):195-9</p>
<p align="left">Marien T,&nbsp;Sankin A, Lepor H.&nbsp;&nbsp;Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy.&nbsp;&nbsp;J Urol.&nbsp;&nbsp;2009 Apr;181(4):1817-22</p>
<p align="left">Sankin A, Tareen B, Lepor H.&nbsp;&nbsp;Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.&nbsp;&nbsp;Prostate Cancer Prostatic Dis.&nbsp;&nbsp;2009;12(2):204-8</p>
<p align="left">Mufarrij P,&nbsp;Sankin A, Godoy G, Lepor H.&nbsp;Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy.&nbsp;&nbsp;Urology.&nbsp;&nbsp;2010 Sep;76(3):689-92</p>
<p align="left">Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N.&nbsp;&nbsp;Rate of renal cell carcinoma subtypes in different races.&nbsp;&nbsp;Int Braz J Urol.&nbsp;&nbsp;2011 Feb;37(1):29-32</p>
<p align="left">Sankin A, Sfakianos J, Schiff J, Sjoberg D, Coleman J.&nbsp;Assessing renal function following partial nephrectomy using renal nuclear scintigraphy and eGFR.&nbsp;&nbsp;Urology.&nbsp;&nbsp;2012 Aug;80(2):343-6</p>
<p align="left">Ghavamian R, Hakimi AA, Williams SK, Kim PH, Chen L, Sfakianos JP, Keren-Paz GE,&nbsp;Sankin A,&nbsp;Ginzburg N, Coleman JA.&nbsp;&nbsp;Factors affecting proportional glomerular filtration rate following minimally invasive partial nephrectomy.&nbsp;&nbsp;J Endourology&nbsp;&nbsp;2013 Nov;27(11):1371-5</p>
<p align="left">Sankin A, Hakimi AA, Mikkilineni N, Ostrovnaya I, Silk MT, Liang Y, Mano R, Chevinsky M, Motzer RJ, Solomon SB, Cheng EH, Durack JC, Coleman JA, Russo P, Hsieh JJ.&nbsp;&nbsp;The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling.&nbsp;&nbsp;Cancer Medicine 2014 Dec;3(6):1485-92</p>
<p align="left">Mano R, Vertosick E,&nbsp;Sankin A,&nbsp;Chevinsky M, Larish Y, Jakubowski CD, Hotker AM, Sjoberg D, Akin O, Russo P.&nbsp;&nbsp;The clinical significance of indeterminate pulmonary nodules in patients with renal cell carcinoma.&nbsp;&nbsp;J Urol 2014 Mar;193(3):776-82</p>
<p align="left">Chevinsky M, Imnadze M,&nbsp;Sankin A, Winer A, Mano R, Jakubowski C, Mashni J, Sjoberg DD, Chen YB, Tickoo SK, Reuter VE, Hakimi AA, Russo P.&nbsp;Pathologic stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma.&nbsp;J Urol 2015 Aug;194(2):310-5</p>
<p align="left">Hakimi AA, Tickoo S, Jacobsen A, Sarungbam J, Sfakianos J, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Chen YB,&nbsp;Sankin A,&nbsp;Mano R, Coleman JA, Russo P, Ogawa S, Sander C, Hsieh JJ, Reuter VE.&nbsp;TCEB1-mutated renal cell carcinoma: a distinct genomic and morphologic subtype.&nbsp;&nbsp;Mod Pathol 2015 June;28(6):845-53</p>
<p align="left">Sankin A,&nbsp;Hakimi AA, Hsieh JJ, Molina AM.&nbsp;&nbsp;Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies.&nbsp;&nbsp;Front Oncol 2015 Apr 8;5:67</p>
<p align="left">Hakimi AA, Ostrovnaya I, Jacobsen A, Susztak K, Coleman JA, Russo P, Winer AG, Mano R,&nbsp;Sankin A, Motzer RJ, Voss MH, Offit K, Purdue M, Pomerantz M, Freedman M, Choueiri TK, Hsieh JJ, Klein RJ.&nbsp;&nbsp;Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell&nbsp;carcinoma.&nbsp;&nbsp;Cancer 2016 Feb 1;122(3):402-10</p>
<p align="left">Sankin A. Discovering biomarkers within the genomic landscape of renal cell carcinoma.&nbsp;&nbsp;J Kidney 2016 Feb 2(1)&nbsp;</p>
<p align="left">Sankin A, Tin A, Mano R, Chevinsky M, Jakubowski C, Cha E, Yee A, Friedman F, Sjoberg D, Ehdaie B, Coleman J.&nbsp;&nbsp;Impact of ureteroscopy prior to nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes.&nbsp;&nbsp;Urology 2016 Aug; 94:148-53</p>
<p align="left">Mano R, Hakimi AA,&nbsp;Sankin AI,&nbsp;Sternberg IA, Chevinsky MS, Russo P.&nbsp;&nbsp;Surgical treatment of tumors involving kidneys with fusion anomalies &ndash; a contemporary series.&nbsp;&nbsp;Urology 2016 Aug; 98:97-102</p>
<p align="left">Zhou TC,&nbsp;Sankin A,&nbsp;Porcelli SA, Perlin DS, Schoenberg MP, Zang XX.&nbsp;&nbsp;A review of the PD-1/PD-L1 checkpoint in bladder cancer: from mediator of immune escape, to target for treatment.&nbsp;&nbsp;Urol Oncol 2017 Jan;35(1):14-20&nbsp;</p>
<p align="left">Winer AG, Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD,&nbsp;Sankin AI,&nbsp;Sfakianos JP, Cha EK, Dalbagni G, Coleman JA.&nbsp;Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.&nbsp;&nbsp;Urol Oncol 2017 April;35(4):151</p>
<p align="left">Sankin&nbsp;A,&nbsp;Narasimhulu&nbsp;D, John P,&nbsp;Gartrell&nbsp;B, Schoenberg M, Zang XX.&nbsp; The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: what lies beneath the tip of the iceberg, PD-L1.&nbsp;&nbsp;Urol&nbsp;Onc&nbsp;2017 (Epub ahead of print)</p>
<p align="left">Milbar N, Kates M, Chappidi MR, Pederzoli F, Yoshida T,&nbsp;Sankin A,&nbsp;Pierorazio PM, Schoenberg MP, Bivalacqua TJ. Oncological outcomes of sequential intravesical gemcitabine and docetaxel in patients with non-muscle invasive bladder cancer.&nbsp;&nbsp;Bladder Cancer 2017 Oct 27;3(4):293-303</p>
<p align="left">Daneshmand S, Patel s, Lotan Y, Pohar K, Trabulsi E, Woods M, Downs T, Huang W, Jones J, O&rsquo;Donnell M, Bivalacqua T, DeCastro J, Steinberg G, Kamat A, Resnick M, Konety B, Schoenberg M, Jones JS,&nbsp;Flexible Blue Light Study Group Collaborators.&nbsp;Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study.&nbsp;&nbsp;J Urol 2018 May;199(5):1158-65</p>
<p align="left">Fridman D, Abeshouse M,&nbsp;Sankin A.&nbsp;Paraurethral Leiomyoma as an Incidental Finding in a Patient with Fibroid Uterus. Case Rep Obstet Gynecol 2018 Feb 7;2018</p>
<p align="left">Adrianzen Hererra DA, Goldberg-Stein S,&nbsp;Sankin A, Sarungbam J, Sharma J, Gartrell BA. Synchronous Bone Metastasis From Multiple Myeloma and Prostate Adenocarcinoma as Initial Presentation of Coexistent Malignancies. Front Oncol, 2018 Apr 30;8:137</p>
<p align="left">Berstein A, Fram EB,&nbsp;Sankin A, Kovac E, Srivastava A, DiVito J, Stern JM. A Comparison of Perinephric Fat Surface Area and Mayo Adhesive Probability Score in Predicting Malignancy in T1 Renal Masses.&nbsp;&nbsp;Urol Onc 2018 Nov; 36(11):499</p>
<p align="left">Sun Y, Reuter VE, Magi-Galluzzi C,&nbsp;Sankin A,&nbsp;Epstein JI.&nbsp;Granular Cell Tumor of the Bladder: A Report of Six Cases.&nbsp;&nbsp;Urology 2018 Nov; 121:203&nbsp;</p>
<p align="left">Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ,&nbsp;Sankin A,&nbsp;Schoenberg MP, Shipley WU, Villers A, Efstathiou J, Bellmunt J, Stenzl A.&nbsp;&nbsp;Recommendations From Joint SIU-ICUD Consultation On Bladder Cancer: Muscle-Invasive Presumably Regional Tumor.&nbsp;&nbsp;World J Urol 2019, Jan;37(1): 61-83</p>
<p align="left">Chand D, Dhawan D,&nbsp;Sankin A, Ren X, Lin J, Schoenberg M, Knapp DW, Zang X. Immune checkpoint B7x (B7-H4/B7S1/VtCN1) is overexpressed in spontaneous canine bladder cancer: the first report and its implications in a preclinical model. Bladder Cancer 2019, Jan 31;5(1)63-71</p>
<p align="left">Bernstein A, Barry E, Fram EB,&nbsp;Sankin A,&nbsp;Kovac E, Stern JM.&nbsp;Does Glomerular Filtration Rate at Discharge After Partial Nephrectomy Predict Long-Term Glomwerular Filtration Rate Stability?. J Endourol 2019, Jun;33(6):488-491</p>
<p align="left">Lotan Y, Bivalacqua TJ, Downs T, Huang W, Jones J, Kamat A, Konety B, Malmstrom PU, McKiernan J, O&rsquo;Donnell M, Patel S, Pohar K, Resnick M,&nbsp;Sankin A,&nbsp;Smith A, Steinberg G, Trabulsi E, Woods M, Daneshmand S.&nbsp;&nbsp;Blue light flexible cystoscopy with hexaminolevulinate in non-muscle invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA &ndash; update 2018. Nat Rev Urol 2019, Jun;16(6):377-386</p>
<p align="left">Sankin A,&nbsp;Chand D, Schoenberg M, Zang X.&nbsp;&nbsp;Human urothelial bladder cancer generates a clonal immune response: the results of T-cell receptor sequencing.&nbsp;&nbsp;Urol Oncol 2019, May 15 (epub ahead of print).</p>
<p align="left">Wang H, Kaur G,&nbsp;Sankin A,&nbsp;Chen F, Guan F, Zang X.&nbsp;Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies.&nbsp;&nbsp;J Hematol Oncol 2019, Jun 11;12(1):59</p>
<p align="left">Daniels MJ, Barry E, Schoenberg M, Lamm DL, Bivalacqua TJ,&nbsp;Sankin A, Kates M.&nbsp;&nbsp;Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer. Urol Oncol 2019, Jun 26 (epub ahead of print)</p>
<p align="left">Daniels MJ, Barry E, Milbar N, Schoenberg M, Bivalacqua TJ,&nbsp;Sankin A, Kates M. An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle invasive bladder cancer.&nbsp;&nbsp;Urol Oncol 2019, Aug 28 (epub ahead of print)</p>
<p align="left">Khaki AR, Li A, Diamantopoulos LN, Bilen MA, Santos V, Esther J, Morales-Barrera R, Devitt M, Nelson A, Holmes CJ, Shreck E, Assi H, Gartrell BA, Sankin A,&nbsp;Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Baratam P, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P.&nbsp;&nbsp;Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors.&nbsp;&nbsp;Cancer 2019, Dec 12 (epub ahead of print)</p>

EMR ID

78143

Biography

<p>Alexander I. Sankin, MD, is Associate Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer.</p><p>After earning his Master of Science from the University of Pennsylvania in 2004, Dr. Sankin earned his Doctor of Medicine from New York University in 2008 and completed his residency in surgery and urology at the State University of New York Downstate in 2013. He then completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in 2015.</p><p>Building on his clinical focus, Dr. Sankin&rsquo;s research centers on bladder-preserving treatment options in patients with high-risk bladder cancer and the development of new immunotherapies for bladder cancer. He is the site-principal investigator for multiple clinical trials studying novel therapeutics for patients with bladder cancer who wish to avoid radical cystectomy. As an active member of multiple clinical trial consortiums, including Eastern Cooperative Oncology Group and the Society of Urologic Oncology Clinical Trials Consortium, Dr. Sankin spearheaded the development of a bladder cancer clinical trials program at Einstein. His translational research focuses on characterizing the tumor immune microenvironment of bladder tumors and the role of novel checkpoint molecules as relevant therapeutic targets. His work has been published in numerous peer-reviewed journals.</p><p>Dr. Sankin is board certified and a member of the American Urological Association and the Society of Urologic Oncology.</p>

Is Open Scheduling

Off

Heather B. Root

https://assets.montefioreeinstein.org/profiles/images/physphoto/Root_Heather_MD_420x504.jpg

First Name

Heather

Last Name

Root

NPI

1003202268

Faculty ID

17044

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

156577

Is Open Scheduling

On

Paul F. Riska

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/70b15a50-3cae-11ec-9e23-c5d5559390c7.jpg

First Name

Paul

Last Name

Riska

NPI

1245274364

Faculty ID

1700

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>My research interests are: Clostridium difficile, Tuberculosis, Molecular epidemiology, Molecular mechanisms of antibiotic resistance, Bacteriophage Therapy.&nbsp;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4063

Is Open Scheduling

Off

Yoram A. Puius

https://assets.montefioreeinstein.org/profiles/images/physphoto/Puius_Yoram_A_MD,PhD_11118591.jpg

First Name

Yoram

Last Name

Puius

NPI

1639291099

Faculty ID

12847

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Yoram Puius completed MD and PhD degrees at the Albert Einstein College of Medicine in 2001. His original research was in the structural biology of signal transduction proteins in the laboratory of Dr. Steven Almo. After completing a residency in Internal Medicine at New York Hospital, he completed a fellowship in Infectious Diseases at Columbia Presbyterian, followed by an additional year at Tufts Medical Center focusing on infections in transplant recipients.</p>
<p>Dr. Puius's first position was at Roger Williams Medical Center in Providence, Rhode Island in 2007. There he served as Medical Director of Infection Control and Assistant Program Director of the Internal Medicine Residency, while holding the rank of Assistant Professor at Boston University School of Medicine. In Rhode Island he further developed interest and expertise in tickborne diseases. In addition, he directed infectious diseases protocols and education for the sole Bone Marrow Transplant Unit in the state of Rhode Island.&nbsp;</p>
<p>Since joining Einstein-Montefiore in 2011, Dr. Puius has worked closely with transplant teams providing inpatient and outpatient consultations, working on protocols for various selection committees, and developing an online transplant infections curriculum. He was promoted to the rank of Associate Professor in 2018.&nbsp; He has also served as Associate Program Director for the Fellowship in Infectious Diseases. He remains clinically active in the evaluation and treatment of tickborne diseases.</p>
<p>Dr. Puius is a member of the Infectious Diseases Society of America, the American Society for Transplantation, the Transplantation Society, and the International Society for Heart and Lung Transplantation. He is on the editorial boards of <em>Clinical Transplantation</em> and <em>Transplant Infectious Diseases</em>, and a reviewer for several other journals.</p>
<p>He publishes and speaks regionally on infections in the immunocompromised host and Lyme disease.&nbsp; He also chairs the working group to maintain the online Transplant Infectious Diseases library for the American Society of Transplantation (AST) ID Community of Practice, at http://transplantid.net/.&nbsp; In addition, he initatied a working group for AST to create standardized patient materials for safe living after transplantation.&nbsp; In 2024 he was selected as a Fellow of the American Society of Transplantation.</p>
<p>Clinical Interests:</p>
<p>- Infections in the immunocompromised host, including recipients of kidney, liver, heart, and stem cell transplants</p>
<p>- Infections in patients with hematological malignancies</p>
<p>- Infections in patients with Left Ventricular Assist Devices</p>
<p>- Lyme disease</p>
<p>- Pre-travel counseling and vaccination for the immunocompromised patient</p>
<p>- Online educational resources in transplant infectious diseases</p>
<p>&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Treating infections in the immunocompromised host, including recipients of solid organ transplants, patients with hematologic malignancies and recipients of cellular therapy.

Research Focus

Infections in left ventricular assist device recipients, heart transplant recipients and kidney transplant recipients.

Elsevier Profile

PubMed.gov URL

Selected Publications

<p class="MsoNormal" style="margin-left: .25in; text-indent: -.25in; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 10pt;"><span style="mso-list: Ignore;">1.<span style="font-style: normal; font-variant: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Levin, S., Mayer, D., <strong>Puius, Y.A.</strong>, Arora, S., and Gileles-Hillel A. (2024) Things We Do for No Reason&trade;: Routine respiratory pathogen panels for emergency department and hospitalized patients.<span style="mso-spacerun: yes;">&nbsp; </span><em>J. Hosp. Med.</em> </span><a href="https://doi.org/10.1002/jhm.13365"><span style="font-size: 10.0pt;">https://doi.org/10.1002/jhm.13365</span></a></p&gt;
<p class="MsoNormal" style="margin-left: .25in;"><span style="font-size: 10pt;">&nbsp;</span></p>
<p class="MsoNormal" style="margin-left: .25in; text-indent: -.25in; mso-list: l0 level1 lfo1;"><span style="font-size: 10pt;"><span style="mso-list: Ignore;">2.&nbsp; </span></span><span style="font-size: 10.0pt;">Mullis, C.E., Heldman, M., Bahr, N.C., Minamoto, G.Y., <strong>Puius. Y.A.</strong>, and Malinis, M. (2024) Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. <em>Transpl Infect Dis</em>. </span><a href="https://doi.org/10.1111/tid.14271"><span style="font-size: 10.0pt;">https://doi.org/10.1111/tid.14271</span></a></p&gt;
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify;"><span style="font-size: 10.0pt;">&nbsp;</span></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Coe J., <strong>Puius, Y.</strong>, Jain, H., and Meyerowitz, E. (2024) Cervical lymphadenitis from <em>Mycobacterium avium</em> complex.<span style="mso-spacerun: yes;">&nbsp; </span><em>BMJ Case Reports</em>.</span> <strong><span style="font-size: 10.0pt;">17</span></strong><span style="font-size: 10.0pt;">(3):e256726. <span style="mso-spacerun: yes;">&nbsp;</span></span><a href="https://doi.org/10.1136/bcr-2023-256726"><span style="font-size: 10.0pt;">https://doi.org/10.1136/bcr-2023-256726</span></a></p&gt;
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify;"><span style="font-size: 10.0pt;">&nbsp;</span></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Arora, S. and <strong>Puius, Y.A.</strong> (2023) Comment on: Community-Acquired Pneumonia.<span style="mso-spacerun: yes;">&nbsp; </span><em>N Engl J Med</em> <strong>389</strong>(17): 1633. </span><a href="https://doi.org/10.1056/nejmc2310748"><span style="font-size: 10.0pt;">https://doi.org/10.1056/nejmc2310748</span></a></p&gt;
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify;"><span style="font-size: 10.0pt;">&nbsp;</span></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Tsai, H., Minamoto, G.Y., and <strong>Puius, Y.A</strong>. (2023) "Chapter 36. Infections in Heart Transplantation" In: Barac, Y.D., Silvestry, S.C., Goldstein, D., Daneshmand M.A. eds. Textbook of Transplantation and Mechanical Support for End-Stage Heart and Lung Disease. Wiley-Blackwell.</span></p>
<p class="MsoListParagraph" style="margin-left: .25in;"><span style="font-size: 10.0pt;">&nbsp;</span></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span class="MsoHyperlink"><span style="font-size: 10.0pt; color: windowtext; text-decoration: none; text-underline: none;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Gould, C.V., Free, R.J., Bhatnagar, J. et al. (2023) Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation, United States, 2021 &ndash; Report of an Investigation. <em>Lancet Microbe</em>. <strong>4</strong>(9):e711-e721.<span style="mso-spacerun: yes;">&nbsp; </span></span><a href="https://doi.org/10.1016/S2666-5247(23)00170-2"><span style="font-size: 10.0pt;">https://doi.org/10.1016/S2666-5247(23)00170-2</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">7.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Azar, M.M., Tsai, H., Vergidis, P., Harris, C.E., Anjan, S., Barros,N., Belga, S., Chuang, S.T., Czeresnia, J.M., Goel, S., Ince, D., Luk, A., Majeed, A., Multani, A., Obedi, K.M., and Swaminathan, N. (2023) <em>transplantid.net</em>:<span style="mso-spacerun: yes;">&nbsp; </span>A Pilot Crowdsourced, Living, Online Library of Resources for the Teaching and Practice of Transplant Infectious Diseases. <em>Open Forum Inf Dis.</em></span> <strong><span style="font-size: 10.0pt;">10</span></strong><span style="font-size: 10.0pt;">(2):ofad081.</span> <a href="https://doi.org/10.1093/ofid/ofad081"><span style="font-size: 10.0pt;">https://doi.org/10.1093/ofid/ofad081</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span class="MsoHyperlink"><span style="font-size: 10.0pt; color: windowtext; text-decoration: none; text-underline: none;"><span style="mso-list: Ignore;">8.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Hemmige, V., Saeed, O., <strong>Puius, Y.A.</strong>, Azzi, Y., Colovai, A., Borgi, J., Goldstein, D.J., Rahmanian, M., Carlese, A., Jorde, U.P., and Patel, S. (2023)<span style="mso-spacerun: yes;">&nbsp; </span>HIV D+/R+ heart/kidney transplantation: first case report. <em>J Heart Lung Transplant</em>.</span> <strong><span style="font-size: 10.0pt;">42</span></strong><span style="font-size: 10.0pt;">(3):406-408. </span><a href="https://doi.org/10.1016/j.healun.2022.11.004"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.healun.2022.11.004</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">9.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Maini, R., Saini, N., Bhavaan, K., Bharti, B., Walia, S., Kori N., Kataria S., Sharma P., Deswal V., Atluri, K., Mandke C, Chansoria M., Rawat, S.K., Bhat, R.S., Dravid, A., Barnawal, C., Sarkar N., Jariwala S., <strong>Puius, Y.A</strong>., Arora, S., Sethi, Y, for the MUNCO Registry. (2022) Clinico-epidemiologic characteristics of patients reported in the Mycotic infections in COVID-19 Registry. <em>Am J Trop Med Hygiene </em><strong>108</strong>(3):584-587<em>.</em> </span><a href="https://doi.org/10.4269/ajtmh.22-0503"><span style="font-size: 10.0pt;">https://doi.org/10.4269/ajtmh.22-0503</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">10.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Arora, S., Narayanan, S., Fazzari, M., Bhavana, K., Bhartendu, B., Walia, S., Kori N., Kataria S., Sharma P., Atluri, K., Mandke C, Gite, V., Redkar, N., Chansoria M., Rawat, S.K., Bhat, R.S., Dravid, A., Sethi, Y., Barnawal, C., Sarkar N.K., Jariwala S., Southern, W., <strong>Puius, Y.A.</strong>, MUNCO Registry (2022) Factors Associated with Mortality in Coronavirus-Associated Mucormycosis: Results from Mycotic Infections in COVID-19 (MUNCO) Online Registry. <em>J Clin Med</em>. <strong>11</strong>(23):7015.<span style="mso-spacerun: yes;">&nbsp; </span></span><a href="https://doi.org/10.3390/jcm11237015"><span style="font-size: 10.0pt;">https://doi.org/10.3390/jcm11237015</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">11.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Castagna F., Xue X., Saeed O., et al. (2022) Hospital bed occupancy rate is an independent risk factor for COVID-19 inpatient mortality: a pandemic epicentre cohort study. <em style="mso-bidi-font-style: normal;">BMJ Open</em>. 12(2):e058171. </span><a href="https://doi.org/10.1136/bmjopen-2021-05817"><span style="font-size: 10.0pt;">https://doi.org/10.1136/bmjopen-2021-05817</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">12.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Thakkar, A., Cui, Z., Peeke, S.Z., et al. (2021) Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Stem Cell Investig</em>. 8:18. </span><a href="https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8449156/"><span style="font-size: 10.0pt;">https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8449156/</span></a></…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">13.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Arora, S., Hemmige, V.S., Mandke, C., Chansoria, M., Rawat, S.K., Dravid, A., Sethi, Y., Medikeri, G., Jariwala, S.P., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2021) Online registry of COVID-19&ndash;associated mucormycosis cases, India, 2021. <em style="mso-bidi-font-style: normal;">Emerg Infect Dis</em>.<strong style="mso-bidi-font-weight: normal;">27</strong>(11) </span><a href="https://wwwnc.cdc.gov/eid/article/27/11/21-1322_article"><span style="font-size: 10.0pt;">https://wwwnc.cdc.gov/eid/article/27/11/21-1322_article</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">14.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Bartash, R. M., and Zingman, B. S. (2021) Maintaining Mask Momentum in Transplant Recipients.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Transplant Infectious Disease</em> <strong style="mso-bidi-font-weight: normal;">23</strong>(4): e13697. </span><a href="https://doi.org/10.1111/tid.13697"><span style="font-size: 10.0pt;">https://doi.org/10.1111/tid.13697</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">15.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Cervera Hernandez, M.E., Szymczak, W., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, and Shuter, J. (2021) Lung, Brain, and Spinal Cord Abscesses After a Near-Drowning Episode.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">American J. Med.</em> </span><a href="https://doi.org/10.1016/j.amjmed.2021.04.039"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.amjmed.2021.04.039</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">16.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Parkar, F., Tlamsa, A.P., Nistico, J.A., Muggia, V.A., Minamoto, G.Y., Jorde, U.P., Goldstein, D.J., and Moadel, R. (2021) Gallium-67 Single Photon Emission Computed Tomography Affects Management of Infections of Left Ventricular Assist Devices.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">ASAIO Journal. </em><strong style="mso-bidi-font-weight: normal;">67</strong>(7):<span style="mso-spacerun: yes;">&nbsp; </span>746-751<span style="mso-spacerun: yes;">&nbsp; </span></span><a href="https://doi.org/10.1097/mat.0000000000001316"><span style="font-size: 10.0pt;">https://doi.org/10.1097/mat.0000000000001316</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">17.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Muggia, V.A. and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong><span style="mso-spacerun: yes;">&nbsp; </span>(2020) <em style="mso-bidi-font-style: normal;">Nocardia ignorata</em> Infection in Heart Transplant Patient.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Emerging Infectious Diseases</em> <strong style="mso-bidi-font-weight: normal;">26</strong>(11):2788-2789. </span><a href="https://doi.org/10.3201/eid2611.202756"><span style="font-size: 10.0pt;">https://doi.org/10.3201/eid2611.202756</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">18.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Nori, P., Szymczak, W., <strong style="mso-bidi-font-weight: normal;">Puius, Y</strong>., Sharma, A., Cowman, K., Gialanella, P., Fleischner, Z., Corpuz, M., Torres-Isasiga, J., Bartash, R., Felsen, U., Chen, V., and Guo, Y. (2020) Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing <em style="mso-bidi-font-style: normal;">Enterobacterales</em> Infections in New York City COVID-19 Patients. <em style="mso-bidi-font-style: normal;">Int. J. Antimicrobial Agents</em> <strong style="mso-bidi-font-weight: normal;">56</strong>(6):106179<span style="mso-spacerun: yes;">&nbsp; </span></span><a href="https://doi.org/10.1016/j.ijantimicag.2020.106179"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.ijantimicag.2020.106179</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">19.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Peraza, J. and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2020) Cutaneous Fungal Infections in Left Ventricular Assist Device Recipients. <em style="mso-bidi-font-style: normal;">Current Fungal Infection Reports</em>.</span> <strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">14</span></strong><span style="font-size: 10.0pt;">:225&ndash;232 </span><a href="https://rdcu.be/b4HaA"><span style="font-size: 10.0pt; background: white; mso-highlight: white;">https://rdcu.be/b4HaA</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">20.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Zheng, C., Quintero, O. Revere, E.K., Oey, M.B., Espinoza, F., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, Ramirez-Baron, D., Salama, C.R., Hidalgo, L.F., Machado, F.S., Saeed, O., Shun, J., Patel, S.R., Coyle, C.M., and Tanowitz, H.B. (2020) Chagas Disease in the New York City Metropolitan Area.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Open Forum Infectious Diseases</em> <strong style="mso-bidi-font-weight: normal;">7</strong>(5):</span> <span style="font-size: 10.0pt;">ofaa156. </span><a href="https://doi.org/10.1093/ofid/ofaa156"><span style="font-size: 10.0pt;">https://doi.org/10.1093/ofid/ofaa156</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">21.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.,</span></strong><span style="font-size: 10.0pt;"> Aldrich, M., and Cope, J.R.<span style="mso-spacerun: yes;">&nbsp; </span>(2020) &ldquo;Acanthamoeba, Naegleria, &amp; Balamuthia in Transplant patients: An Emerging Threat.&rdquo; In: Morris, M., Kotton, C., Wolfe, C. (eds) Emerging Transplant Infections, pp. <span style="mso-spacerun: yes;">&nbsp;</span>1451-1472 Springer, Cham, Switzerland.<span style="mso-spacerun: yes;">&nbsp; </span></span><a href="https://link.springer.com/referenceworkentry/10.1007%2F978-3-030-01751-… style="font-size: 10.0pt; background: white; mso-highlight: white;">https://link.springer.com/referenceworkentry/10.1007%2F978-3-030-01751-…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">22.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Quintero Cardona, O., Hemmige, V., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong><span style="mso-spacerun: yes;">&nbsp; </span>(2020) Methenamine Hippurate May Have Particular Benefit in Preventing Recurrent Urinary Tract Infections in Diabetic Renal Transplant Recipients. <em style="mso-bidi-font-style: normal;">Transplant Infectious Diseases,</em> <strong style="mso-bidi-font-weight: normal;">22</strong>(2): e13247 </span><a href="https://doi.org/10.1111/tid.13247"><span style="font-size: 10.0pt;">https://doi.org/10.1111/tid.13247</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">23.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Jorde, U.P., Shah, A.M., Sims, D.B., Madan, S., Siddiqi, N., Luke, A., Saeed, O., Patel, S.R., Murthy S., Shin, J., Oviedo, J., Watts, S., Jakobleff, W., Forest, S., Vukelic, S., Belov, D., <strong style="mso-bidi-font-weight: normal;">Puius, Y.</strong>, Minamoto, G., Muggia, V., Carlese, A., Leung, S., Rahmanian, M., Leff, J., Goldstein, D. (2019) Continuous-flow left ventricular device survival improves with multidisciplinary approach.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Annals of Thoracic Surgery</em>. <strong style="mso-bidi-font-weight: normal;">108</strong>(2):508-516. </span><a href="https://doi.org/10.1016/j.athoracsur.2019.01.063"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.athoracsur.2019.01.063</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">24.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Patel S.R., Madan, S., Saeed, O., Sims D.B., Shin, J.J., Nucci, C., Borukhov, E., Goldstein, D.Y., Jakobleff, W., Forest, S., Vukelic, S., Murthy, S., Reinus, J., <strong style="mso-bidi-font-weight: normal;">Puius, Y</strong>., Goldstein, D.J., Jorde, U.P. (2018)<span style="mso-spacerun: yes;">&nbsp; </span>Cardiac transplantation from non-viremic hepatitis C donors. <em style="mso-bidi-font-style: normal;">J Heart Lung Transplant</em>. <strong style="mso-bidi-font-weight: normal;">37</strong>(10): 1254-1260. </span><a href="https://doi.org/10.1016/j.healun.2018.06.012"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.healun.2018.06.012</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">25.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt; color: black;">Mogoll&oacute;n, J.E., Szymczak, W.A., Levi, M.H., Patel, H., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A</strong>. (2018) Case #17015: Renal recipient with two weeks of progressive shortness of breath, fatigue, and bilateral lower extremity swelling. <em style="mso-bidi-font-style: normal;">Partners Infectious Disease Images</em>, </span><a href="https://www.idimages.org/idreview/case/?CaseID=544"><span style="font-size: 10.0pt;">https://www.idimages.org/idreview/case/?CaseID=544</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">26.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt; color: black;">Muggia, V.A., Minamoto, G.Y., Forest, S.J., Lerman, D.T., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2018)<span style="mso-spacerun: yes;">&nbsp; </span>&ldquo;Chapter 3:<span style="mso-spacerun: yes;">&nbsp; </span>Left Ventricular Assist Device Infections: A Practical Approach.&rdquo;<span style="mso-spacerun: yes;">&nbsp; </span>In:<span style="mso-spacerun: yes;">&nbsp; </span>Ventricular Assist Devices: Management, Outcomes and Complications.<span style="mso-spacerun: yes;">&nbsp; </span>Ren&eacute; Murielle, ed.<span style="mso-spacerun: yes;">&nbsp; </span>Nova Science Publishers., Inc., Happauge, NY. </span><a href="https://novapublishers.com/wp-content/uploads/2019/01/978-1-53613-891-7… style="font-size: 10.0pt;">https://novapublishers.com/wp-content/uploads/2019/01/978-1-53613-891-7…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">27.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Kutner, A., Aldrich, M. Patel, S. Kang, J. J., Amin, B. Mann, R., Ali I. M., Brasil Martines, R., Cope, J. R., De Boccardo, G. O., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2018)<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Acanthamoeba</em> Endophthalmitis During Treatment for Cutaneous Disease in a Renal Transplant Patient.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Transplant Infectious Diseases</em>, <strong style="mso-bidi-font-weight: normal;">20</strong>(2):e12483 </span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6110267/"><span style="font-size: 10.0pt;">http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6110267/</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">28.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Levy, D.T., Peck, N., Minamoto, G.Y., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, D&rsquo;Alessandro, D.A., Goldstein, D. and Muggia, V.A.<span style="mso-spacerun: yes;">&nbsp; </span>(2015)<span style="mso-spacerun: yes;">&nbsp; </span>Role of gallium SPECT-CT in the diagnosis of left ventricular assist device infections:<span style="mso-spacerun: yes;">&nbsp; </span>A case series and review of the literature.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">ASAIO Journal</em>, <strong style="mso-bidi-font-weight: normal;">61</strong>(1):<span style="mso-spacerun: yes;">&nbsp; </span>e5-e10. </span><a href="https://doi.org/10.1097/mat.0000000000000167"><span style="font-size: 10.0pt;">https://doi.org/10.1097/mat.0000000000000167</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">29.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Levy, D.T., Guo, Y., Simkins, J., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, Muggia, V.A., Goldstein, D.J., D'Alessandro, D.A., and Minamoto, G.Y. (2014) Left ventricular assist device exchange for persistent infection: a case series and review of the literature. <em style="mso-bidi-font-style: normal;"><span style="color: black;">Transplant Infectious Diseases</span></em><span style="color: black;">, <strong style="mso-bidi-font-weight: normal;">16</strong>(3): 453-460. </span></span><a href="https://doi.org/10.1111/tid.12207"><span style="font-size: 10.0pt;">https://doi.org/10.1111/tid.12207</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; font-variant: small-caps;"><span style="mso-list: Ignore;">30.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;">, Sonder, G. B., and Mileno, M. (2013)<span style="mso-spacerun: yes;">&nbsp; </span>&ldquo;Chapter 27:<span style="mso-spacerun: yes;">&nbsp; </span>The Immunocompromised Traveler&rdquo;<span style="mso-spacerun: yes;">&nbsp; </span>In:<span style="mso-spacerun: yes;">&nbsp; </span>Travel Medicine, 3^rd Edition, Jay Keystone, Ed., pp. 265-272.<span style="mso-spacerun: yes;">&nbsp; </span>Elsevier. </span><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000272"… style="font-size: 10.0pt;">https://www.sciencedirect.com/science/article/pii/B9781455710768000272<…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; font-variant: small-caps;"><span style="mso-list: Ignore;">31.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt; color: black;">Irizarry-Acosta, M. and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2010) Post-influenza pneumonia:<span style="mso-spacerun: yes;">&nbsp; </span>Everything old is new again.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Medicine and Health in Rhode Island,</em> <strong style="mso-bidi-font-weight: normal;">93</strong>: 204-211. </span><a href="http://www.rimed.org/medhealthri/2010-07/2010-07-204.pdf"><span style="font-size: 10.0pt;">http://www.rimed.org/medhealthri/2010-07/2010-07-204.pdf</span></a></p&…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">32.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;"> and Kalish, R.A. (2008) Lyme Arthritis:<span style="mso-spacerun: yes;">&nbsp; </span>Pathogenesis, Clinical Presentation, and Management.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Infectious Disease Clinics of North America</em>, <strong style="mso-bidi-font-weight: normal;">22</strong>: 289-300. </span><a href="https://doi.org/10.1016/j.idc.2007.12.014"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.idc.2007.12.014</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">33.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;">, Shah, D.P., Brust, D.G., Dove, L.M., and Lefkowitch, J.H.<span style="mso-spacerun: yes;">&nbsp; </span>(2008) Three Cases of Autoimmune Hepatitis in HIV Infected Patients.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Journal of Clinical Gastroenterology</em>, <strong style="mso-bidi-font-weight: normal;">42</strong>:<span style="mso-spacerun: yes;">&nbsp; </span>425-429. </span><a href="https://doi.org/10.1097/01.mcg.0000225591.08825.3e"><span style="font-size: 10.0pt;">https://doi.org/10.1097/01.mcg.0000225591.08825.3e</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">34.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;"> and Snydman, D.R. (2007) Prophylaxis and treatment of CMV disease in recipients of solid organ transplants:<span style="mso-spacerun: yes;">&nbsp; </span>Current approach and future challenges.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Current Opinion in Infectious Diseases</em> <strong style="mso-bidi-font-weight: normal;">20</strong>:<span style="mso-spacerun: yes;">&nbsp; </span>419-424. </span><a href="https://doi.org/10.1097/qco.0b013e32821f6026"><span style="font-size: 10.0pt;">https://doi.org/10.1097/qco.0b013e32821f6026</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">35.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;"> and Scully, B. (2007) Treatment of <em style="mso-bidi-font-style: normal;">Candida albicans</em> pericarditis in a heart transplant patient.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Transplant Infectious Diseases</em> <strong style="mso-bidi-font-weight: normal;">9</strong>:<span style="mso-spacerun: yes;">&nbsp; </span>229-232. </span><a href="https://doi.org/10.1111/j.1399-3062.2006.00195.x"><span style="font-size: 10.0pt;">https://doi.org/10.1111/j.1399-3062.2006.00195.x</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">36.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Stievater, T.H., and Srikrishnan, T. (2006) Crystal structure, conformation, and absolute configuration of kanamycin A.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Carbohydrate Research</em> <strong style="mso-bidi-font-weight: normal;">341</strong>:<span style="mso-spacerun: yes;">&nbsp; </span>2871-2875. </span><a href="https://doi.org/10.1016/j.carres.2006.09.008"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.carres.2006.09.008</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">37.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt; color: black;">Dewan, J.C., Feeling-Taylor, A., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, Patskovska, L., Patskovsky, Y., Nagel, R.L., Almo, S.C., and Hirsch, R.E.</span> <span style="font-size: 10.0pt; color: black;">(2002) Structure of mutant human carbonmonoxyhemoglobin C (&beta;E6K) at 2.0 &Aring; resolution.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Acta Crystallographica</em> <strong style="mso-bidi-font-weight: normal;">D58</strong>:<span style="mso-spacerun: yes;">&nbsp; </span>2038-2042. </span><a href="https://doi.org/10.1107/s0907444902016426"><span style="font-size: 10.0pt;">https://doi.org/10.1107/s0907444902016426</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">38.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Sarmiento, M., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, Vetter, S.W., Keng, Y.-F., Wu, L., Zhao, Y., Lawrence, D.S., Almo, S.C., and Zhang, Z.-Y.<span style="mso-spacerun: yes;">&nbsp; </span>(2000) Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Biochemistry</em> <strong style="mso-bidi-font-weight: normal;">39</strong>:<span style="mso-spacerun: yes;">&nbsp; </span>8171-8179. </span><a href="https://doi.org/10.1021/bi000319w"><span style="font-size: 10.0pt;">https://doi.org/10.1021/bi000319w</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">39.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Fedorov, E.V., Eichinger, L., Schleicher, M., and Almo, S.C. (2000) Mapping the functional surface of domain 2 in the gelsolin superfamily.<span style="mso-spacerun: yes;">&nbsp; </span><em style="mso-bidi-font-style: normal;">Biochemistry</em> <strong style="mso-bidi-font-weight: normal;">39</strong>:<span style="mso-spacerun: yes;">&nbsp; </span>5322-5331. </span><a href="https://doi.org/10.1021/bi992364d"><span style="font-size: 10.0pt;">https://doi.org/10.1021/bi992364d</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">40.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Zou, M., Ho, N.T., Ho, C., and Almo, S.C. (1998) Novel water-mediated hydrogen bonds as the structural basis for the low oxygen affinity of the blood substitute candidate rHb(&alpha;96Val</span><span style="font-size: 10.0pt; font-family: Cardo; mso-fareast-font-family: Cardo; mso-bidi-font-family: Cardo;">&rarr;Trp). </span><em style="mso-bidi-font-style: normal;"><span style="font-size: 10.0pt;">Biochemistry</span></em><span style="font-size: 10.0pt;"> <strong style="mso-bidi-font-weight: normal;">37</strong>:<span style="mso-spacerun: yes;">&nbsp; </span>9258-65. </span><a href="https://doi.org/10.1021/bi9727287"><span style="font-size: 10.0pt;">https://doi.org/10.1021/bi9727287</span></a></p&gt;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">41.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Mahoney, N.M., and Almo, S.C. (1998) The modular structure of actin-regulatory proteins.<em style="mso-bidi-font-style: normal;"> Current Opinion in Cell Biology </em><strong style="mso-bidi-font-weight: normal;"><span style="mso-spacerun: yes;">&nbsp;</span>10:</strong> 23-34. </span><a href="https://doi.org/10.1016/s0955-0674(98)80083-5"><span style="font-size: 10.0pt;">https://doi.org/10.1016/s0955-0674(98)80083-5</span></a></p&gt;
<div style="mso-element: para-border-div; border: none; border-bottom: solid black 1.0pt; mso-border-bottom-alt: solid black .5pt; padding: 0in 0in 1.0pt 0in;">
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; border: none; mso-border-bottom-alt: solid black .5pt; padding: 0in; mso-padding-alt: 0in 0in 1.0pt 0in; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">42.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Zhao, Y., Sullivan, M., Lawrence, D.S., Almo, S.C., and Zhang, Z.-Y. (1997) Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. <em style="mso-bidi-font-style: normal;"><span style="mso-spacerun: yes;">&nbsp;</span>Proceedings of the National Academy of Sciences of the U.S.A. </em><strong style="mso-bidi-font-weight: normal;"><span style="mso-spacerun: yes;">&nbsp;</span>94:</strong> 13420-13425. </span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc28320/"><span style="font-size: 10.0pt;">http://www.ncbi.nlm.nih.gov/pmc/articles/pmc28320/</span></a></p&gt;
</div>

EMR ID

5504

Biography

<p>Yoram A. Puius, MD, PhD, is an attending physician, Associate Professor, Medicine and Associate Professor, Cardiothoracic &amp; Vascular Surgery at Montefiore Einstein. His clinical focus centers on treating infections in the immunocompromised host, including recipients of solid organ transplants, patients with hematologic malignancies and recipients of cellular therapy.</p><p>After obtaining his Bachelor of Arts in physics from Cornell University in 1992, Dr. Puius earned his Doctor of Philosophy in biochemistry at Einstein in 1999, followed by his Doctor of Medicine in 2001. He moved to NewYork-Presbyterian Hospital-Cornell to complete his internal medicine residency in 2003 and an infectious diseases fellowship at NewYork-Presbyterian Hospital-Columbia in 2006. Following this, Dr. Puius completed an additional year focusing on infectious in the immunocompromised host at Tufts Medical Center in 2007.</p><p>Building on his clinical focus, Dr. Puius&rsquo;s research involves infections in left ventricular assist device recipients, heart transplant recipients and kidney transplant recipients. In addition, he is the architect of the online transplant infectious disease library, &ldquo;transplantid.net&rdquo; for the American Society of Transplantation. He is also involved in research on COVID-19-associated Mucormycosis. Dr. Puius&rsquo;s work has been published in numerous peer-reviewed journals, books, chapters and review articles, and he has presented abstracts and poster presentations nationally. He has been a reviewer for a number of journals and is on the editorial boards of <em>Clinical Transplantation</em> and <em>Transplant Infectious Diseases</em>.</p><p>Dr. Puius is board certified in Internal Medicine and Infectious Diseases. He is a member of many professional organizations, including the Infectious Diseases Society of America, the American Society of Transplantation and the International Society for Heart and Lung Transplantation. He is also the Founding Chair of the Transplant Infectious Diseases Online Library Working Group for the American Society of Transplantation. In 2021, Dr. Puius was named Heart Failure &amp; Transplant Consultant of the Year at Montefiore. He has also been named in Castle Connolly&rsquo;s &ldquo;Top Doctors&rdquo; for multiple years.</p>

Is Open Scheduling

Off

Kari M. Plewniak

https://assets.montefioreeinstein.org/profiles/images/physphoto/Plewniak_Kari_MD_420x504.jpg

First Name

Kari

Last Name

Plewniak

NPI

1053759472

Faculty ID

15938

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Plewniak&rsquo;s clinical focus is the gynecologic care of women. She primarily treats women with abnormal bleeding, fibroids, endometriosis and pelvic pain. Her clinical interests include laparoscopy, robotics, hysteroscopy in the office and surgical teaching.

Research Focus

Dr. Plewniak&rsquo;s research has been focused on the patient experience leading up to and after surgery as well as approaches to optimizing patient outcomes and satisfaction.&nbsp;

Elsevier Profile

EMR ID

3126

Biography

<p>Kari M. Plewniak, MD, is Attending Physician at Montefiore and Assistant Professor at our Albert Einstein College of Medicine. Dr. Plewniak&rsquo;s clinical focus is the gynecologic care of women. She primarily treats women with abnormal bleeding, fibroids, endometriosis and pelvic pain. Her clinical interests include laparoscopy, robotics, hysteroscopy in the office and surgical teaching.</p><p>After receiving her Bachelor of Science in Neuroscience from the University of Rochester in 2008, Dr. Plewniak attended Albert Einstein College of Medicine, receiving her Doctor of Medicine in 2013. For her postdoctoral training, she completed a four-year residency at Beth Israel Deaconess Medical Center in 2017, followed by a two-year fellowship in Minimally Invasive Gynecologic Surgery at Montefiore Medical Center in 2019.</p><p>Dr. Plewniak&rsquo;s research has been focused on the patient experience leading up to and after surgery as well as approaches to optimizing patient outcomes and satisfaction. She has produced several book chapters, and her research findings have been published in reviewed publications.</p><p>Dr. Plewniak received the Louis Burke Award for Excellence in Colposcopy in 2017. In 2018 and 2019, she received the Leo Davidoff Society Award for excellence in medical student education. She is board certified and a member of the American Congress of Obstetricians and Gynecologists and the American Association of Gynecologic Laparoscopists.</p>

Is Open Scheduling

Off

Liise-anne Pirofski

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f4f1a2e0-7ad6-11ed-ab80-5f85f7731f77.jpg

First Name

Liise-anne

Last Name

Pirofski

NPI

1376633271

Faculty ID

8131

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Liise-anne Pirofski is a physician-scientist. Her research programs focus on host-microbe interaction and antibody immunity to infectious diseases.</p>
<p>She is chief of the Division of Infectious Diseases and the Jacques and Selma Mitrani Chair in Biomedical Research at Albert Einstein College of Medicine and Montefiore Medical Center. She is a member of the American Association of Physicians (AAP) and a fellow of the American Academy of Microbiology (AAM), American College of Physicians (ACP), Infectious Diseases Society of America (FIDSA), and the American Association for the Advancement of Science (AAAS). She is deeply devoted to biomedical education and mentoring for which she has received numerous accolades, including the American Society for Microbiology William A Hinton Award, the Infectious Diseases Society of America Walter E. Stamm Mentor Award, and the Albert Einstein College of Medicine Faculty Mentoring Award, Harry Eagle Award for Outstanding Basic Science Teaching, and the Lifetime Achievement Award from the Albert Einstein College of Medicine Alumni Association.</p>
<p>Dr. Pirofski received Bachelor of Arts degrees from the University of California, Berkeley in History of Art and Psychology, and her Medical degree from the Albert Einstein College of Medicine.</p>
<p>For more information, visit the <a title="Visit the division of infectious diseases" href="/departments/medicine/divisions/infectious-diseases/">Division of Infectious Diseases website</a>.</p>
<p><strong>More Information About Dr. Liise-anne Pirofski</strong></p>
<ul role="list">
<li><a href="/departments/medicine/news/pirofski-wins-faculty-mentoring-award.aspx" target="_blank" rel="noopener">Dr. Pirofski Receives Faculty Mentoring Award</a></li>
<li><a href="/uploadedFiles/departments/medicine/JID%20supplement%20published%20version.pdf" target="_blank" rel="noopener">Life as an Infectious Diseases Physician Scientist: Science is Humanity&rsquo;s Lifeline</a></li>
<li><a href="/pirofski_LAA_Award_2017.aspx" target="_blank" rel="noopener">2017 Alumni Association Lifetime Achievement Award</a></li>
<li><a href="https://www.idsociety.org/about-idsa/awards/the-walter-e.-stamm-mentor-…. Pirofski Receives the Infectious Diseases of America Walter E. Stamm Mentor Award (idsociety.org)</a></li>
</ul>

Research Areas

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<div>A leading physician-scientist, Dr. Pirofski studies vaccine and antibody mediated immunity to infectious diseases, including cryptococcosis (the leading cause of fungal meningitis globally), pneumococcal pneumonia, and COVID-19. Her work has identified novel ways by which antibodies protect against pneumonia and the spread of fungal infections. She has spearheaded studies to understand the antibody response to the novel coronavirus, SARS-CoV-2.<br /><br /></div>
<div>Dr. Pirofski is co-author of the &ldquo;damage-response framework of microbial pathogenesis,&rdquo; a novel theory that incorporates the role of the host into the outcome of host-microbe interactions and infectious diseases.<br /><br /></div>
<div>As chief of the division of infectious diseases, Dr. Pirofski helped lead the Einstein and Montefiore response to the COVID-19 pandemic. She also co-authored a widely-cited commentary in the <em>Journal of Clinical Investigation</em> proposing the use of convalescent plasma as a potential treatment for COVID-19 and is leading Einstein and Montefiore&rsquo;s participation in a randomized placebo-controlled clinical trial to test the efficacy of convalescent plasma in hospitalized patients.<br /><br /></div>
<div>Dr. Pirofski, who has been continuously funded by the National Institutes of Health throughout her career, is a member of the American Association of Physicians and a fellow of the American Academy of Microbiology, American College of Physicians, the Infectious Diseases Society of America, and the American Association for the Advancement of Science. She has received numerous awards for her accomplishments, including the Lifetime Achievement Award from the Albert Einstein College of Medicine Alumni Association.</div>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p><a href="https://www.ncbi.nlm.nih.gov/pubmed?term=Pirofski%20L%20%5bAuthor%20Nam… src="/images/logo/pubmed.png" alt="pubmed" /></strong></a></p>

EMR ID

3596

Is Open Scheduling

Off